2025-07-23 Drugs SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder
2025-07-10 Drugs The SFDA Approves the Registration of “Winrevair” for the Treatment of Pulmonary Arterial Hypertension under the Orphan Drug Designation Pathway
2025-05-26 Drugs The SFDA Grants Breakthrough Designation to "Itovebi" for Advanced Hormone Resistant Breast Cancer Treatment
2025-05-22 Drugs The SFDA Grants Breakthrough Designation to “MIQNAF” for Acute Bacterial Infections Treatment
2025-05-13 Drugs The SFDA Grants Breakthrough Designation to Atrasentan (Vanrafia) for Primary Immunoglobulin A (IgA) Nephropathy
2025-05-05 Drugs The SFDA Approves Breakthrough Designation Application for Breast Cancer Therapy “Inluriyo”
2025-05-04 Drugs The SFDA Approves Clinical Trial for Novel Biologic Therapy for Genetic Propionic Acidemia
